IP Verse

Revance Therapeutics, Inc. v. Medy-Tox, Inc. - IPR2021-01204

Explore the PTAB proceeding IPR2021-01204 filed by Revance Therapeutics, Inc. against Medy-Tox, Inc. on Jul 1, 2021. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2021-01204
Filing Date
Jul 1, 2021
Petitioner
Revance Therapeutics, Inc.
Respondent
Medy-Tox, Inc.
Status
Institution Denied
Respondent Application Number
14567289
Respondent Tech Center
1600
Respondent Patent Number
9480731
Institution Decision Date
Jan 19, 2022
Termination Date
Jan 19, 2022

Decision Documents New

Decision pending - set alert to receive updates

Counsels Involved New

Details of counsels involved in proceeding number IPR2021-01204.

TypeName
Petitioner CounselEldora Ellison
Respondent CounselEdward Gates

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.